FOXG1 is overexpressed in hepatoblastoma

Human Pathology

Volumn 38, Issue 3, 2007, Pages 400-409

  Adesina, Adekunle Michael ^a   Nguyen, Yummy ^a   Guanaratne, Preethi ^a,c   Pulliam, Joseph ^a   Lopez Terrada, Dolores ^a   Margolin, Judy ^b   Finegold, Milton ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c University of Houston   (United States)

Author keywords

BAC array Comparative Genomic Hybridization; FOXG1; gene amplification; hepatoblastoma; pediatric neoplasia, liver tumors

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CHROMOSOME 14Q; CHROMOSOME 17Q; CHROMOSOME 19P; CHROMOSOME 1P; CHROMOSOME 1Q; CHROMOSOME 2; CHROMOSOME 20; CHROMOSOME 4P; CHROMOSOME 5P; CHROMOSOME 6P; CHROMOSOME 6Q; CHROMOSOME 8; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOSTASIS; FOXG1 GENE; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE INDUCTION; GENE LOCUS; GENE OVEREXPRESSION; GENE REPRESSION; HEPATOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ONCOGENE; P21CIP1 GENE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TELOMERE; TUMOR DIFFERENTIATION; UPREGULATION;

CYCLIN-DEPENDENT KINASE INHIBITOR P21; FORKHEAD TRANSCRIPTION FACTORS; HEPATOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; PROTEIN KINASE C; UP-REGULATION;

EID: 33846865104     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.09.003     Document Type: Article

References (48)

1. Perilongo G., and Shafford E.A. Liver tumours. Eur J Cancer 35 (1999) 953-958
2. Kuniyasu H., Yasui W., Shimamoto F., et al. Hepatoblastoma in an adult associated with c-met protooncogene imbalance. Pathol Int 46 (1996) 1005-1010
3. Ahn H.J., Kwon K.W., Choi Y.J., et al. Mixed hepatoblastoma in an adult-a case report and literature review. J Korean Med Sci 12 (1997) 369-373
4. Parada L.A., Bardi G., Hallen M., et al. Cytogenetic abnormalities and clonal evolution in an adult hepatoblastoma. Am J Surg Pathol 21 (1997) 1381-1386
5. Mueller B.U., Lopez-Terrada D., and Finegold M.J. Tumors of the liver. In: Pizzo P.A., and Poplack D.G. (Eds). Principles and practice of pediatric oncology. 5th ed. (2006), Lippincott Williams and Wilkins, Philadelphia 887-904
6. Feusner J., and Plaschkes J. Hepatoblastoma and low birth weight: a trend or chance observation?. Med Pediatr Oncol 39 (2002) 508-509
7. Tomlinson G.E., Douglass E.C., Pollock B.H., Finegold M.J., and Schneider N.R. Cytogenetic evaluation of a large series of hepatoblastomas: numerical abnormalities with recurring aberrations involving 1q12-q21. Genes, Chromosomes Cancer 44 (2005) 177-184
8. Terracciano L.M., Bernasconi B., Ruck P., et al. Comparative genomic hybridization analysis of hepatoblastoma reveals high frequency of X-chromosome gains and similarities between epithelial and stromal components. Hum Pathol 34 (2003) 864-871
9. Martynoga B., Morrison H., Price D.J., and Mason J.O. FOXG1 is required for specification of ventral telencephalon and region-specific regulation of dorsal telencephalic precursor proliferation and apoptosis. Dev Biol 283 (2005) 113-127
10. Muzio L., and Mallamaci A. FOXG1 confines Cajal-Retzius neuronogenesis and hippocampal morphogenesis to the dorsomedial pallium. J Neurosci 25 (2005) 4435-4441
11. Hanachima C., Li S.C., Shen L., Lai E., and Fishell G. FOXG1 suppresses early cortical cell fate. Science 303 (2004) 56-59
12. Dou C., Lee J., Liu B., et al. BF-1 interferes with transforming growth factor β signaling by associating with smad partners. Mol Cell Biol 20 (2000) 6201-6211
13. Bourguignon C., Li J., and Papalopulu N. XBF-1, a winged helix transcription factor with dual activity has a role in positioning neurogenesis in Xenopus competent ectoderm. Development 125 (1998) 4889-4900
14. Ahlgren S., Vogt P., and Bronner-Fraser M. Excess FOXG1 causes overgrowth of the neural tube. J Neurobiol 57 (2003) 337-349
15. Arden K. Fox O: linking new signaling pathways. Mol Cell 14 (2004) 416-418
16. Weinberg A.G., and Finegold M.J. Primary hepatic tumors of childhood. Hum Pathol 14 (1983) 512-537
17. Yang Y.H., Dudoit S., Luu P., Peng V., Ngai J., and Speed T.P. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nuclei Acid Res 30 (2002) e15
18. Draghici S. Data pre-processing and normalization. In: Draghici S. (Ed). Data analysis tools for microarrays (2003), Chapman Hall/CRC, Norwell, MA 309-340
19. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98 (2001) 5116-5121
20. Tonk V.S., Wilson K.S., Timmons C.F., and Schneider N.R. Trisomy 2, trisomy 20, and del(17p) as sole chromosomal abnormalities in three cases of hepatoblastoma. Genes Chromosome Cancer 11 (1994) 199-202
21. Yeh Y.A., Rao P.H., Cigna C.T., Middlesworth W., Lefkowitch J.H., and Murty V.V. Trisomy 1q, 2, and 20 in a case of hepatoblastoma: possible significance of 2q35-q37 and 1q12-q21 rearrangements. Cancer Genet Cytogenet 123 (2000) 140-143
22. Kumon K., Kobayashi H., Namiki T., et al. Frequent increase of DNA copy number in the 2q24 chromosomal region and its association with a poor clinical outcome in hepatoblastoma: cytogenetic and comparative genomic hybridization analysis. Jpn J Cancer Res 92 (2001) 854-862
23. Ma S.K., Cheung A.N., Choy C., et al. Cytogenetic characterization of childhood hepatoblastoma. Cancer Genet Cytogenet 119 (2000) 32-36
24. Nagata T., Mugishima H., Shichino H., et al. Karyotypic analyses of hepatoblastoma. Report of two cases and review of the literature suggesting chromosomal loci responsible for the pathogenesis of this disease. Cancer Genet Cytogenet 114 (1999) 42-50
25. Parada L.A., Limon J., Iliszko M., et al. Cytogenetics of hepatoblastoma: further characterization of 1q rearrangements by fluorescence in situ hybridization: an international collaborative study. Med Pediatr Oncol 34 (2000) 165-170
26. Park J.P., Ornvold K.T., Brown A.M., and Mohandas T.K. Trisomy 2 and 19, and tetrasomy 1q and 14 in hepatoblastoma. Cancer Genet Cytogenet 115 (1999) 86-87
27. Schneider N.R., Cooley L.D., Finegold M.J., Douglas E.C., and Tomlinson G.E. The first recurring chromosome translocation in hepatoblastoma: der(4)t(1;4)(q12;q34). Genes Chromosome Cancer 19 (1997) 291-294
28. Buendia M.A. Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects. Med Pediatr Oncol 39 (2002) 530-535
29. Fausto N., Laird A.D., and Webber E.M. Role of growth factors and cytokines in hepatic regeneration. FASEB J 9 (1995) 1527-1536
30. Matsuzaki K., Date M., Furukawa F., et al. Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellular carcinoma: implications for roles of smads in its growth. Hepatology 32 (2000) 218-227
31. Bedossa P., Peltier E., Terris B., Franco D., and Poynard T. Transforming growth factor-beta 1 (TGF-β1) and TGF-β1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology 21 (1995) 760-766
32. Shirai Y., Kawata S., Tamura S., et al. Plasma transforming growth factor-β1 in patients with hepatocellular carcinoma. Cancer 73 (1994) 2275-2279
33. Polakis P. Wnt signaling and cancer. Genes Dev 14 (2000) 1837-1851
34. Udatsu Y., Kusafuka T., Kuroda S., Miao J., and Okada A. High frequency of beta-catenin mutations in hepatoblastoma. Pediatr Surg Int 17 (2001) 508-512
35. Miao J., Kusafuka T., Udatsu Y., and Okada A. Sequence variants of the Axin gene in hepatoblastoma. Hepatol Res 25 (2003) 174-179
36. Blaker H., Hofmann W.J., Rieker R.J., Penzel R., Graf M., and Otto H.F. Beta-catenin accumulation and mutation of the CTNNB1 gene in hepatoblastoma. Genes Chromosomes Cancer 25 (1999) 399-402
37. Jeng Y.M., Wu M.Z., Mao T.L., Chang M.H., and Hsu H.C. Somatic mutations of beta-catenin play a crucial role in the tumorigenesis of sporadic hepatoblastoma. Cancer Lett 152 (2000) 45-51
38. Koch A., Denkhaus D., Albrecht S., Leuschner I., von Schweinitz D., and Pietsch T. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. Cancer Res 59 (1999) 269-273
39. Wei Y., Fabre M., Branchereau S., Gauthier F., Perilongo G., and Buendia M.A. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas. Oncogene 19 (2000) 498-504
40. Moon R.T., Bowerman B., Boutros M., and Perrimon N. The promise and perils of Wnt signaling through beta-catenin. Science 296 (2002) 1644-1646
41. Alexandrow M.G., and Moses H.L. Transforming growth factor β and cell cycle regulation. Cancer Res 55 (1995) 1452-1457
42. Warner B.J., Blain S.W., Seoane J., and Massagué J. Myc downregulation by transforming growth factor b required for activation of the p15Ink4b G1 arrest pathway. Mol Cell Biol 19 (1999) 5913-5922
43. Park W.S., Dong S.M., Kim S.Y., et al. Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas. Cancer Res 59 (1999) 307-310
44. Monga S.P., Mars W.M., Pediaditakis P., et al. Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes. Cancer Res 62 (2002) 2064-2071
45. Jou T.S., Stewart D.B., Stappert J., Nelson W.J., and Marrs J.A. Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex. Proc Natl Acad Sci USA 92 (1995) 5067-5071
46. Ruck P., and Xiao J.C. Stem-like cells in hepatoblastoma. Med Pediatr Oncol 39 (2002) 504-507
47. Manolagas S.C. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21 (2000) 115-137
48. Spinella-Jaegle S., Rawadi G., Kawai S., et al. Sonic hedgehog increases the commitment of pluripotent mesenchymal cells into the osteoblastic lineage and abolishes adipocytic differentiation. J Cell Sci 114 (2001) 2085-2094